| Medical and Health Sciences | Lifetime | 20 | CA 2 | 100.00 |
| Medical and Health Sciences | 2021-2025 | 641 | CA 23 | 99.86 |
| Cardiology and Cardiovascular Medicine | Lifetime | 2 | CA 1 | 100.00 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 116 | CA 3 | 99.65 |
| Surgery | Lifetime | 401 | CA 19 | 99.66 |
| Organizational Behavior and Human Resource Management | Lifetime | 169 | CA 15 | 99.51 |
| Public, Environmental and Occupational Health | Lifetime | 452 | CA 27 | 99.36 |
| Econometrics and Quantitative Economics | Lifetime | 724 | CA 18 | 99.32 |
| Internal Medicine | Lifetime | 49 | CA 15 | 99.04 |
| Nutrition and Dietetics | Lifetime | 259 | CA 11 | 98.79 |
| Pulmonary and Respiratory Medicine | Lifetime | 710 | CA 34 | 98.94 |
| Family Practice | Lifetime | 35 | CA 6 | 97.96 |
| Complementary and Alternative Medicine | Lifetime | 425 | CA 29 | 97.50 |
| Statistics, Probability and Uncertainty | Lifetime | 307 | CA 27 | 97.12 |
| Radiology, Nuclear Medicine and Imaging | Lifetime | 962 | CA 22 | 97.30 |
| Statistics and Probability | Lifetime | 468 | CA 37 | 96.29 |
| Nephrology | Lifetime | 830 | CA 32 | 86.78 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 208 | CA 14 | 98.54 |
| Public, Environmental and Occupational Health | 2021-2025 | 646 | CA 39 | 93.85 |
| Blood Pressure and Hypertension Studies | Lifetime | 1 | CA 1 | 99.97 |
| Cardiovascular Health and Risk Factors | Lifetime | 1 | CA 1 | 99.97 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 5 | CA 2 | 99.96 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 9 | CA 1 | 99.95 |
| Cardiovascular Function and Risk Factors | Lifetime | 20 | CA 1 | 99.93 |
| Global Public Health Policies and Epidemiology | Lifetime | 5 | CA 1 | 99.88 |
| Heart Failure Treatment and Management | Lifetime | 8 | CA 1 | 99.95 |
| Acute Myocardial Infarction Research | Lifetime | 17 | CA 1 | 99.94 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 24 | CA 7 | 99.88 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 23 | CA 6 | 99.86 |
| Cardiac, Anesthesia and Surgical Outcomes | Lifetime | 59 | CA 6 | 99.75 |
| Medication Adherence and Compliance | Lifetime | 7 | CA 1 | 99.63 |
| Pharmaceutical Economics and Policy | Lifetime | 7 | CA 1 | 99.52 |
| Cardiac Health and Mental Health | Lifetime | 20 | CA 1 | 99.66 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 34 | CA 1 | 99.82 |
| Cardiovascular Disease and Adiposity | Lifetime | 59 | CA 3 | 99.60 |
| Cardiac electrophysiology and arrhythmias | Lifetime | 118 | CA 8 | 99.59 |
| Lipoproteins and Cardiovascular Health | Lifetime | 77 | CA 5 | 99.55 |
| Cardiac Imaging and Diagnostics | Lifetime | 197 | CA 6 | 99.65 |
| Diabetes Treatment and Management | Lifetime | 130 | CA 6 | 99.43 |
| Cardiac pacing and defibrillation studies | Lifetime | 139 | CA 10 | 99.49 |
| Sodium Intake and Health | Lifetime | 39 | CA 3 | 99.08 |
| Cardiac Arrhythmias and Treatments | Lifetime | 259 | CA 16 | 99.23 |
| Statistical Methods in Clinical Trials | Lifetime | 73 | CA 8 | 98.47 |
| Heart Rate Variability and Autonomic Control | Lifetime | 359 | CA 16 | 98.67 |
| Nutritional Studies and Diet | Lifetime | 310 | CA 8 | 98.89 |
| Hormonal Regulation and Hypertension | Lifetime | 306 | CA 12 | 98.46 |
| Health Promotion and Cardiovascular Prevention | Lifetime | 61 | CA 2 | 98.33 |
| Acute Ischemic Stroke Management | Lifetime | 437 | CA 27 | 98.69 |
| Coronary Interventions and Diagnostics | Lifetime | 352 | CA 14 | 98.96 |
| Pharmacology and Obesity Treatment | Lifetime | 130 | CA 7 | 98.40 |
| Renin-Angiotensin System Studies | Lifetime | 144 | CA 5 | 98.25 |
| Aortic aneurysm repair treatments | Lifetime | 315 | CA 8 | 98.11 |
| Meta-analysis and systematic reviews | Lifetime | 115 | CA 20 | 98.10 |
| Potassium and Related Disorders | Lifetime | 79 | CA 5 | 98.17 |
| Cardiovascular Health and Disease Prevention | Lifetime | 411 | CA 10 | 98.09 |
| Vascular Procedures and Complications | Lifetime | 278 | CA 13 | 97.97 |
| Obesity, Physical Activity, Diet | Lifetime | 726 | CA 34 | 98.37 |
| Hemodynamic Monitoring and Therapy | Lifetime | 400 | CA 27 | 97.71 |
| Genetic Associations and Epidemiology | Lifetime | 504 | CA 14 | 97.44 |
| Peripheral Artery Disease Management | Lifetime | 552 | CA 12 | 96.94 |
| Cardiac and Coronary Surgery Techniques | Lifetime | 361 | CA 34 | 96.94 |
| Health disparities and outcomes | Lifetime | 880 | CA 45 | 97.05 |
| Heart rate and cardiovascular health | Lifetime | 46 | CA 3 | 96.66 |
| Cardiovascular and exercise physiology | Lifetime | 855 | CA 62 | 96.85 |
| Aortic Disease and Treatment Approaches | Lifetime | 904 | CA 48 | 96.68 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | Lifetime | 593 | CA 20 | 93.71 |
| Nutrition, Genetics, and Disease | Lifetime | 753 | CA 30 | 92.63 |
| Cardiovascular Syncope and Autonomic Disorders | Lifetime | 877 | CA 41 | 93.27 |
| Vitamin K Research Studies | Lifetime | 342 | CA 15 | 91.26 |
| Health and Medical Research Impacts | Lifetime | 672 | CA 49 | 89.57 |
| Pericarditis and Cardiac Tamponade | Lifetime | 564 | CA 24 | 88.74 |
| Advanced Causal Inference Techniques | Lifetime | 965 | CA 38 | 82.62 |
| Sex and Gender in Healthcare | Lifetime | 546 | CA 51 | 77.74 |
| Global Health and Epidemiology | Lifetime | 474 | CA 12 | 72.00 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 37 | CA 1 | 99.10 |
| Medication Adherence and Compliance | 2021-2025 | 31 | CA 1 | 96.10 |
| Nutritional Studies and Diet | 2021-2025 | 292 | CA 8 | 96.11 |
| Antiplatelet Therapy and Cardiovascular Diseases | 2021-2025 | 164 | CA 6 | 96.30 |
| Sodium Intake and Health | 2021-2025 | 52 | CA 3 | 94.42 |
| Atrial Fibrillation Management and Outcomes | 2021-2025 | 900 | CA 51 | 94.05 |
| Global Public Health Policies and Epidemiology | 2021-2025 | 234 | CA 13 | 89.72 |
| Health disparities and outcomes | 2021-2025 | 924 | CA 44 | 90.29 |
| Heart Failure Treatment and Management | 2021-2025 | 741 | CA 31 | 91.57 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 580 | CA 25 | 90.00 |
| Cardiovascular Health and Risk Factors | 2021-2025 | 375 | CA 5 | 87.39 |
| Pharmaceutical Economics and Policy | 2021-2025 | 625 | CA 28 | 77.16 |
| Health Promotion and Cardiovascular Prevention | 2021-2025 | 533 | CA 21 | 58.61 |